Summary: A random group of 50 patients in tumor
stages T1-3N0-2M0 was selected from breast cancer patients and given Ukrain
therapy by intravenous injection. Twenty-five patients received a total dose
of 50 mg Ukrain (5 mg every second day, 10 injections altogether). Twenty-five
patients received a total dose of 100 mg Ukrain (10 mg every second day, 10
injections altogether).